Frontier sites in clinical trials: Opportunities, challenges, and models
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Frontier sites can increase clinical trial capacity and diversity by reaching new populations. However, they need significant operational support, education, and community engagement to overcome challenges like infrastructure deficiencies and compliance concerns.
Area Of Science
- Clinical Research Operations
- Health Equity
- Healthcare Innovation
Background
- The clinical trials industry faces a capacity gap due to increased study volume and site/staff shortages.
- The Site Enablement League (SEL) Task Force on Frontier Sites was formed to explore non-traditional research sites.
- Frontier sites aim to expand access to underserved populations and integrate research into communities.
Purpose Of The Study
- To define frontier sites and assess their benefits, challenges, and support needs.
- To gather perspectives from individuals with direct experience and those with perceptions of frontier sites.
- To inform strategies for addressing clinical trial capacity and diversity issues.
Main Methods
- A survey was conducted with 29 valid responses from experienced and perception respondents.
- Qualitative and quantitative analysis of free-text responses was performed after coding.
- Perspectives on benefits, challenges, and support needs related to frontier sites were collected.
Main Results
- Access to new participant populations was the most frequently cited benefit.
- Operational infrastructure deficiencies were the primary challenge identified by all respondents.
- Experienced respondents reported greater concerns regarding compliance and community resistance.
- Enhanced operational support and quality oversight were identified as key support needs.
Conclusions
- Frontier sites hold significant potential for enhancing research capacity and diversity.
- Successful integration requires substantial support in operations, education, and community engagement.
- Industry-wide education and a "playbook" are needed for effective frontier site implementation.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...